nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000974	0.000974	CcSEcCtD
Glycopyrrolate—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000974	0.000974	CcSEcCtD
Glycopyrrolate—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000972	0.000972	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000963	0.000963	CcSEcCtD
Glycopyrrolate—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000962	0.000962	CcSEcCtD
Glycopyrrolate—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000954	0.000954	CcSEcCtD
Glycopyrrolate—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000954	0.000954	CcSEcCtD
Glycopyrrolate—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000951	0.000951	CcSEcCtD
Glycopyrrolate—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000951	0.000951	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000951	0.000951	CcSEcCtD
Glycopyrrolate—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000951	0.000951	CcSEcCtD
Glycopyrrolate—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.00095	0.00095	CcSEcCtD
Glycopyrrolate—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000945	0.000945	CcSEcCtD
Glycopyrrolate—Infection—Cisplatin—peripheral nervous system neoplasm	0.000945	0.000945	CcSEcCtD
Glycopyrrolate—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000944	0.000944	CcSEcCtD
Glycopyrrolate—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000941	0.000941	CcSEcCtD
Glycopyrrolate—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000936	0.000936	CcSEcCtD
Glycopyrrolate—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000936	0.000936	CcSEcCtD
Glycopyrrolate—Rash—Topotecan—peripheral nervous system neoplasm	0.000936	0.000936	CcSEcCtD
Glycopyrrolate—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000935	0.000935	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000932	0.000932	CcSEcCtD
Glycopyrrolate—Headache—Topotecan—peripheral nervous system neoplasm	0.00093	0.00093	CcSEcCtD
Glycopyrrolate—Rash—Tretinoin—peripheral nervous system neoplasm	0.000928	0.000928	CcSEcCtD
Glycopyrrolate—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000928	0.000928	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000928	0.000928	CcSEcCtD
Glycopyrrolate—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000928	0.000928	CcSEcCtD
Glycopyrrolate—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000927	0.000927	CcSEcCtD
Glycopyrrolate—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000927	0.000927	CcSEcCtD
Glycopyrrolate—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000927	0.000927	CcSEcCtD
Glycopyrrolate—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000925	0.000925	CcSEcCtD
Glycopyrrolate—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000924	0.000924	CcSEcCtD
Glycopyrrolate—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.000924	0.000924	CcSEcCtD
Glycopyrrolate—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000923	0.000923	CcSEcCtD
Glycopyrrolate—Headache—Tretinoin—peripheral nervous system neoplasm	0.000922	0.000922	CcSEcCtD
Glycopyrrolate—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000922	0.000922	CcSEcCtD
Glycopyrrolate—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000921	0.000921	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00092	0.00092	CcSEcCtD
Glycopyrrolate—Pain—Vincristine—peripheral nervous system neoplasm	0.000919	0.000919	CcSEcCtD
Glycopyrrolate—Constipation—Vincristine—peripheral nervous system neoplasm	0.000919	0.000919	CcSEcCtD
Glycopyrrolate—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000919	0.000919	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000919	0.000919	CcSEcCtD
Glycopyrrolate—Rash—Melphalan—peripheral nervous system neoplasm	0.000916	0.000916	CcSEcCtD
Glycopyrrolate—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000915	0.000915	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000912	0.000912	CcSEcCtD
Glycopyrrolate—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.000911	0.000911	CcSEcCtD
Glycopyrrolate—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000905	0.000905	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000902	0.000902	CcSEcCtD
Glycopyrrolate—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000888	0.000888	CcSEcCtD
Glycopyrrolate—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000888	0.000888	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000887	0.000887	CcSEcCtD
Glycopyrrolate—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000886	0.000886	CcSEcCtD
Glycopyrrolate—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000882	0.000882	CcSEcCtD
Glycopyrrolate—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000882	0.000882	CcSEcCtD
Glycopyrrolate—Nausea—Topotecan—peripheral nervous system neoplasm	0.000882	0.000882	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000879	0.000879	CcSEcCtD
Glycopyrrolate—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000878	0.000878	CcSEcCtD
Glycopyrrolate—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000875	0.000875	CcSEcCtD
Glycopyrrolate—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000875	0.000875	CcSEcCtD
Glycopyrrolate—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000874	0.000874	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000871	0.000871	CcSEcCtD
Glycopyrrolate—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000871	0.000871	CcSEcCtD
Glycopyrrolate—Infection—Etoposide—peripheral nervous system neoplasm	0.000865	0.000865	CcSEcCtD
Glycopyrrolate—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000864	0.000864	CcSEcCtD
Glycopyrrolate—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000863	0.000863	CcSEcCtD
Glycopyrrolate—Nausea—Melphalan—peripheral nervous system neoplasm	0.000863	0.000863	CcSEcCtD
Glycopyrrolate—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000855	0.000855	CcSEcCtD
Glycopyrrolate—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00085	0.00085	CcSEcCtD
Glycopyrrolate—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00085	0.00085	CcSEcCtD
Glycopyrrolate—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00085	0.00085	CcSEcCtD
Glycopyrrolate—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000846	0.000846	CcSEcCtD
Glycopyrrolate—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000843	0.000843	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000842	0.000842	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000822	0.000822	CcSEcCtD
Glycopyrrolate—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000822	0.000822	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000821	0.000821	CcSEcCtD
Glycopyrrolate—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000814	0.000814	CcSEcCtD
Glycopyrrolate—Pain—Cisplatin—peripheral nervous system neoplasm	0.000813	0.000813	CcSEcCtD
Glycopyrrolate—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000803	0.000803	CcSEcCtD
Glycopyrrolate—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000801	0.000801	CcSEcCtD
Glycopyrrolate—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.0008	0.0008	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000798	0.000798	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000792	0.000792	CcSEcCtD
Glycopyrrolate—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000789	0.000789	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000783	0.000783	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000774	0.000774	CcSEcCtD
Glycopyrrolate—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000774	0.000774	CcSEcCtD
Glycopyrrolate—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000771	0.000771	CcSEcCtD
Glycopyrrolate—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.00077	0.00077	CcSEcCtD
Glycopyrrolate—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000766	0.000766	CcSEcCtD
Glycopyrrolate—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000766	0.000766	CcSEcCtD
Glycopyrrolate—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000766	0.000766	CcSEcCtD
Glycopyrrolate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000765	0.000765	CcSEcCtD
Glycopyrrolate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000759	0.000759	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000752	0.000752	CcSEcCtD
Glycopyrrolate—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000752	0.000752	CcSEcCtD
Glycopyrrolate—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000751	0.000751	CcSEcCtD
Glycopyrrolate—Constipation—Etoposide—peripheral nervous system neoplasm	0.000745	0.000745	CcSEcCtD
Glycopyrrolate—Pain—Etoposide—peripheral nervous system neoplasm	0.000745	0.000745	CcSEcCtD
Glycopyrrolate—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000744	0.000744	CcSEcCtD
Glycopyrrolate—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000743	0.000743	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000738	0.000738	CcSEcCtD
Glycopyrrolate—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000738	0.000738	CcSEcCtD
Glycopyrrolate—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000734	0.000734	CcSEcCtD
Glycopyrrolate—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000722	0.000722	CcSEcCtD
Glycopyrrolate—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000718	0.000718	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000718	0.000718	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000717	0.000717	CcSEcCtD
Glycopyrrolate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000715	0.000715	CcSEcCtD
Glycopyrrolate—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000712	0.000712	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000712	0.000712	CcSEcCtD
Glycopyrrolate—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000711	0.000711	CcSEcCtD
Glycopyrrolate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000709	0.000709	CcSEcCtD
Glycopyrrolate—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000708	0.000708	CcSEcCtD
Glycopyrrolate—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000708	0.000708	CcSEcCtD
Glycopyrrolate—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000708	0.000708	CcSEcCtD
Glycopyrrolate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000704	0.000704	CcSEcCtD
Glycopyrrolate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000703	0.000703	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.0007	0.0007	CcSEcCtD
Glycopyrrolate—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000699	0.000699	CcSEcCtD
Glycopyrrolate—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000692	0.000692	CcSEcCtD
Glycopyrrolate—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000689	0.000689	CcSEcCtD
Glycopyrrolate—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000689	0.000689	CcSEcCtD
Glycopyrrolate—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000689	0.000689	CcSEcCtD
Glycopyrrolate—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000689	0.000689	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000684	0.000684	CcSEcCtD
Glycopyrrolate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000684	0.000684	CcSEcCtD
Glycopyrrolate—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000682	0.000682	CcSEcCtD
Glycopyrrolate—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000679	0.000679	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000679	0.000679	CcSEcCtD
Glycopyrrolate—Rash—Vincristine—peripheral nervous system neoplasm	0.000678	0.000678	CcSEcCtD
Glycopyrrolate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000677	0.000677	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000675	0.000675	CcSEcCtD
Glycopyrrolate—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000674	0.000674	CcSEcCtD
Glycopyrrolate—Headache—Vincristine—peripheral nervous system neoplasm	0.000674	0.000674	CcSEcCtD
Glycopyrrolate—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000668	0.000668	CcSEcCtD
Glycopyrrolate—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000665	0.000665	CcSEcCtD
Glycopyrrolate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000663	0.000663	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000642	0.000642	CcSEcCtD
Glycopyrrolate—Nausea—Vincristine—peripheral nervous system neoplasm	0.000639	0.000639	CcSEcCtD
Glycopyrrolate—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000638	0.000638	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000638	0.000638	CcSEcCtD
Glycopyrrolate—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000637	0.000637	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000633	0.000633	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000628	0.000628	CcSEcCtD
Glycopyrrolate—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000625	0.000625	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000625	0.000625	CcSEcCtD
Glycopyrrolate—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000623	0.000623	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000619	0.000619	CcSEcCtD
Glycopyrrolate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000616	0.000616	CcSEcCtD
Glycopyrrolate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000604	0.000604	CcSEcCtD
Glycopyrrolate—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000602	0.000602	CcSEcCtD
Glycopyrrolate—Rash—Cisplatin—peripheral nervous system neoplasm	0.000599	0.000599	CcSEcCtD
Glycopyrrolate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000599	0.000599	CcSEcCtD
Glycopyrrolate—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000598	0.000598	CcSEcCtD
Glycopyrrolate—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000598	0.000598	CcSEcCtD
Glycopyrrolate—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.00059	0.00059	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.00059	0.00059	CcSEcCtD
Glycopyrrolate—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000589	0.000589	CcSEcCtD
Glycopyrrolate—Tension—Epirubicin—peripheral nervous system neoplasm	0.000587	0.000587	CcSEcCtD
Glycopyrrolate—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000586	0.000586	CcSEcCtD
Glycopyrrolate—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000581	0.000581	CcSEcCtD
Glycopyrrolate—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000576	0.000576	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000573	0.000573	CcSEcCtD
Glycopyrrolate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000565	0.000565	CcSEcCtD
Glycopyrrolate—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000564	0.000564	CcSEcCtD
Glycopyrrolate—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000557	0.000557	CcSEcCtD
Glycopyrrolate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000554	0.000554	CcSEcCtD
Glycopyrrolate—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000554	0.000554	CcSEcCtD
Glycopyrrolate—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000554	0.000554	CcSEcCtD
Glycopyrrolate—Agitation—Epirubicin—peripheral nervous system neoplasm	0.00055	0.00055	CcSEcCtD
Glycopyrrolate—Rash—Etoposide—peripheral nervous system neoplasm	0.000549	0.000549	CcSEcCtD
Glycopyrrolate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000549	0.000549	CcSEcCtD
Glycopyrrolate—Headache—Etoposide—peripheral nervous system neoplasm	0.000546	0.000546	CcSEcCtD
Glycopyrrolate—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000545	0.000545	CcSEcCtD
Glycopyrrolate—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000543	0.000543	CcSEcCtD
Glycopyrrolate—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000542	0.000542	CcSEcCtD
Glycopyrrolate—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000538	0.000538	CcSEcCtD
Glycopyrrolate—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000529	0.000529	CcSEcCtD
Glycopyrrolate—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000522	0.000522	CcSEcCtD
Glycopyrrolate—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000518	0.000518	CcSEcCtD
Glycopyrrolate—Nausea—Etoposide—peripheral nervous system neoplasm	0.000517	0.000517	CcSEcCtD
Glycopyrrolate—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000516	0.000516	CcSEcCtD
Glycopyrrolate—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000509	0.000509	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000506	0.000506	CcSEcCtD
Glycopyrrolate—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000498	0.000498	CcSEcCtD
Glycopyrrolate—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000492	0.000492	CcSEcCtD
Glycopyrrolate—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000489	0.000489	CcSEcCtD
Glycopyrrolate—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000488	0.000488	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000488	0.000488	CcSEcCtD
Glycopyrrolate—Infection—Epirubicin—peripheral nervous system neoplasm	0.000485	0.000485	CcSEcCtD
Glycopyrrolate—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.00048	0.00048	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000479	0.000479	CcSEcCtD
Glycopyrrolate—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000478	0.000478	CcSEcCtD
Glycopyrrolate—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000477	0.000477	CcSEcCtD
Glycopyrrolate—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000474	0.000474	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000472	0.000472	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000468	0.000468	CcSEcCtD
Glycopyrrolate—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000461	0.000461	CcSEcCtD
Glycopyrrolate—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000456	0.000456	CcSEcCtD
Glycopyrrolate—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000456	0.000456	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000452	0.000452	CcSEcCtD
Glycopyrrolate—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000452	0.000452	CcSEcCtD
Glycopyrrolate—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000449	0.000449	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000443	0.000443	CcSEcCtD
Glycopyrrolate—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000442	0.000442	CcSEcCtD
Glycopyrrolate—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000441	0.000441	CcSEcCtD
Glycopyrrolate—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000439	0.000439	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000437	0.000437	CcSEcCtD
Glycopyrrolate—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000434	0.000434	CcSEcCtD
Glycopyrrolate—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.00043	0.00043	CcSEcCtD
Glycopyrrolate—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000422	0.000422	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000422	0.000422	CcSEcCtD
Glycopyrrolate—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000421	0.000421	CcSEcCtD
Glycopyrrolate—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000418	0.000418	CcSEcCtD
Glycopyrrolate—Pain—Epirubicin—peripheral nervous system neoplasm	0.000418	0.000418	CcSEcCtD
Glycopyrrolate—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000409	0.000409	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000402	0.000402	CcSEcCtD
Glycopyrrolate—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000402	0.000402	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000399	0.000399	CcSEcCtD
Glycopyrrolate—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000398	0.000398	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.00039	CcSEcCtD
Glycopyrrolate—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.000389	CcSEcCtD
Glycopyrrolate—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000388	0.000388	CcSEcCtD
Glycopyrrolate—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000386	0.000386	CcSEcCtD
Glycopyrrolate—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000386	0.000386	CcSEcCtD
Glycopyrrolate—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000386	0.000386	CcSEcCtD
Glycopyrrolate—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000386	0.000386	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.000372	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000369	0.000369	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00036	0.00036	CcSEcCtD
Glycopyrrolate—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000359	0.000359	CcSEcCtD
Glycopyrrolate—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000357	0.000357	CcSEcCtD
Glycopyrrolate—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000357	0.000357	CcSEcCtD
Glycopyrrolate—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00035	0.00035	CcSEcCtD
Glycopyrrolate—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000345	0.000345	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000333	0.000333	CcSEcCtD
Glycopyrrolate—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000324	0.000324	CcSEcCtD
Glycopyrrolate—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000323	0.000323	CcSEcCtD
Glycopyrrolate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00032	0.00032	CcSEcCtD
Glycopyrrolate—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00031	0.00031	CcSEcCtD
Glycopyrrolate—Rash—Epirubicin—peripheral nervous system neoplasm	0.000308	0.000308	CcSEcCtD
Glycopyrrolate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000308	0.000308	CcSEcCtD
Glycopyrrolate—Headache—Epirubicin—peripheral nervous system neoplasm	0.000306	0.000306	CcSEcCtD
Glycopyrrolate—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.000299	CcSEcCtD
Glycopyrrolate—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00029	0.00029	CcSEcCtD
Glycopyrrolate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000287	CcSEcCtD
Glycopyrrolate—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.000285	CcSEcCtD
Glycopyrrolate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.000285	CcSEcCtD
Glycopyrrolate—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000283	CcSEcCtD
Glycopyrrolate—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.000268	CcSEcCtD
